7-143222550-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_176882.2(TAS2R40):āc.472T>Gā(p.Phe158Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000285 in 1,614,216 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_176882.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS2R40 | NM_176882.2 | c.472T>G | p.Phe158Val | missense_variant | 1/1 | ENST00000408947.4 | NP_795363.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R40 | ENST00000408947.4 | c.472T>G | p.Phe158Val | missense_variant | 1/1 | NM_176882.2 | ENSP00000386210 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000401 AC: 10AN: 249330Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135262
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1461882Hom.: 0 Cov.: 31 AF XY: 0.0000234 AC XY: 17AN XY: 727244
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152334Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 27, 2022 | The c.472T>G (p.F158V) alteration is located in exon 1 (coding exon 1) of the TAS2R40 gene. This alteration results from a T to G substitution at nucleotide position 472, causing the phenylalanine (F) at amino acid position 158 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at